2022
DOI: 10.1016/j.jcms.2022.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonate therapy in chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible: Retrospective case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…In the study by Van de Meent et al . 29 , a reduction in activity was noted in seven patients, no activity in two patients, no change in one patient, and an increase in activity in one patient post-bisphosphonate therapy. Finally, in the study by Montonen et al .…”
Section: Resultsmentioning
confidence: 87%
See 3 more Smart Citations
“…In the study by Van de Meent et al . 29 , a reduction in activity was noted in seven patients, no activity in two patients, no change in one patient, and an increase in activity in one patient post-bisphosphonate therapy. Finally, in the study by Montonen et al .…”
Section: Resultsmentioning
confidence: 87%
“…Furthermore, 76.7% of patients developed hypocalcaemia which typically occurred on the second day of treatment, and 14% of patients developed hypokalaemia which typically occurred on day three of treatment. In the study by van de Meent et al 29 , six of the eighteen patients reported an acute phase reaction, with transient complaints of headache, fever, and flu-like symptoms. Sælen et al 30 reported that only one out of the eight patients treated developed influenza like symptoms.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…This case series described techniques for remodelling surgery in patients with DSO/TP of the mandible, that experienced residual mandibular deformity (i.e. facial asymmetry) after their DSO complaints had been successfully treated using non-surgical treatment options (conservative treatment and/or bisphosphonate therapy) ( 7 , 8 , 10 ). The patients in this case series had therefore been free of DSO complaints for more than six months.…”
Section: Discussionmentioning
confidence: 99%